India Animal Vaccine Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

India animal vaccine market is estimated to grow at a CAGR of around 8.1% during the forecast period. India is the third-largest producer of egg and the fourth-largest producer of chicken across the globe. Poultry is one of the most organized sectors in animal husbandry in India. The country has a rich source of high-quality poultry products such as meat, eggs, and milk. As per the Department of Animal Husbandry and Dairying (DAHD), poultry sector in India was valued at nearly $11.9 billion during the period 2015-2016. The egg production in the country has increased from around 83 billion nos. in 2015-16 to around 88 billion in 2016-17 registering a growth of nearly 6%. The per capita availability of egg has increased from 61 in 2013-14 to 66 in 2015-16. In 2016-17 it is 69. This represents a rising focus on poultry production in the country.

Get Free Sample Copy @ https://www.omrglobal.com/industry-reports/india-animal-vaccine-market

Additionally, the rising meat consumption along with the meat exports to several countries across the globe marks the significant requirement of animal vaccines to protect animals from diseases and viruses. Some of the common animal diseases prevalent in the country include anthrax, a black quarter (black-leg), foot and mouth diseases, rabies, blue tongue, brucellosis in sheep, listeriosis, campylobacter abortion, Johne’s disease, and rinderpest, among others. This, in turn, leads the demand for animal vaccines in the country.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/india-animal-vaccine-market

Some crucial players in the India animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., and Ceva Santé Animale. These players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations to maintain their competitiveness and increase their market share. For instance, in March 2016, Ceva entered into the Indian market with the acquisition of Polchem. With this acquisition, Ceva will enable to develop the Polchem range of products domestically and globally and Polchem will set up advanced products and services of Ceva in the Indian market. 

Market Segmentation

By Type

  • Porcine Vaccines
  • Poultry Vaccines
  • Livestock Vaccines
  • Aquaculture Vaccines
  • Companion Animal Vaccines
  • Other Animal Vaccines

By Technology

  • Live Attenuated Vaccine
  • Killed/Inactive Vaccine
  • Recombinant Vaccine
  • Vectored Vaccine
  • Subunit Vaccine 
  • DNA Vaccine
  • Chimeric Vaccine
  • Others

Company Profiles

  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Elanco
  • Hester Biosciences Ltd. 
  • Indovax Pvt. Ltd.
  • Merck & Co., Inc.
  • Neogen Corp.
  • SEPPIC
  • Vetoquinol S.A.
  • Virbac SA
  • Zoetis, Inc.

(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)